Inhibition of the ʟ-glutamine transporter ASCT2 sensitizes plasma cell myeloma cells to proteasome inhibitors-Reference-Cited by-同舟云学术

Inhibition of the ʟ-glutamine transporter ASCT2 sensitizes plasma cell myeloma cells to proteasome inhibitors

Published:2021-06 Issue: Volume:507 Page:13-25
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Prelowska Monika K.^ORCID,Mehlich Dawid,Ugurlu M. Talha^ORCID,Kedzierska Hanna^ORCID,Cwiek Aleksandra^ORCID,Kosnik Artur^ORCID,Kaminska Klaudia^ORCID,Marusiak Anna A.^ORCID,Nowis Dominika^ORCID

Funder

Fundacja na rzecz Nauki Polskiej

Narodowe Centrum Nauki

Ministerstwo Nauki i Szkolnictwa Wyższego

European Regional Development Fund

European Commission

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference41 articles.

1. Multiple myeloma;Kumar;Nat. Rev. Dis. Prim.,2017

2. Bortezomib-resistant myeloma cell lines: a role for mutated PSMB5 in preventing the accumulation of unfolded proteins and fatal ER stress;Ri;Leukemia,2010

3. Overexpression of the PSMB5 gene contributes to bortezomib resistance in T-lymphoblastic lymphoma/leukemia cells derived from Jurkat line;Lü;Exp. Hematol.,2008

4. Different mutants of PSMB5 confer varying bortezomib resistance in T lymphoblastic lymphoma/leukemia cells derived from the Jurkat cell line;Lü;Exp. Hematol.,2009

5. Impaired bortezomib binding to mutant β5 subunit of the proteasome is the underlying basis for bortezomib resistance in leukemia cells;Franke;Leukemia,2012

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer knocks you out by fasting: Cachexia as a consequence of metabolic alterations in cancer;Journal of Cellular Physiology;2024-09-08

2. Metabolomic biomarkers of multiple myeloma: A systematic review;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-09

3. Asparagine transport through SLC1A5/ASCT2 and SLC38A5/SNAT5 is essential for BCP‐ALL cell survival and a potential therapeutic target;British Journal of Haematology;2024-05-13

4. Targeting myeloma metabolism: How abnormal metabolism contributes to multiple myeloma progression and resistance to proteasome inhibitors;Neoplasia;2024-04

5. The Interaction between Collagen 1 and High Mannose Type CD133 Up‐Regulates Glutamine Transporter SLC1A5 to Promote the Tumorigenesis of Glioblastoma Stem Cells;Advanced Science;2023-11-23